First Page | Document Content | |
---|---|---|
Date: 2016-03-06 19:26:29Health Medical research Pharmaceutical industry Health research Clinical trial Biotechnology Doug Hilton | Mr Bill Ferris AC, Chair, Innovation & Science Australia, Dr Alan Finkel AO FTSE, Chief Scientist of Australia and Mr John Fraser, Secretary to the Treasury C/- R&D Tax Incentive Review Secretariat GPO Box 9839, CANBERRAAdd to Reading ListSource URL: aamri.org.auDownload Document from Source WebsiteFile Size: 266,77 KBShare Document on Facebook |
Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBTDocID: 1xTqy - View Document | |
PDF DocumentDocID: 1wroO - View Document | |
Building A Better Mousetrap: Patenting Biotechnology In The European CommunityDocID: 1vr7C - View Document | |
BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prodDocID: 1vq6b - View Document | |
Biotechnology Consultation Agency Response Letter BNFDocID: 1vpUZ - View Document |